Objective: Chest tubes induce morbidity such as pain, decrease mobility, increase the risk of infection, and prolong the length of hospital stays. This study evaluates a chest-tube protocol containing a high-drainage threshold and a short time period of drainage. Methods: A retrospective study was performed with data collected from all elective complete video-assisted thoracoscopic (c-VATS) (bi-)lobectomies between March 2006 and December 2009. All patients had one chest-tube, postoperatively. The chest tube was removed if there was no air leakage and there was a drainage volume of 400 ml (24 h) À1 or less. We aimed to remove the chest tube on postoperative day 1. Results: This series consists of 110 lobectomies and six bilobectomies. The median duration of chest-tube placement was 1.0 day. In 58.8% of patients (confidence interval (CI) 95%: 49.5-68.0), the drain was removed within 24 h of operation and in 82.5% (CI 95%: 74.2-88.7) within 48 h. In six (6.2%) patients, subcutaneous emphysema developed while the drain was still in place, and was treated with removal of the drain. Persistent air leakage was seen in four (3.4%) patients. One (0.9%) persisting pneumothorax was diagnosed. A pneumothorax after removal of the drain was not diagnosed. No major complications developed in 98 patients (84.5%). The median day of discharge was postoperative day 4. Conclusions: This study shows it is safe, after c-VATS (bi-)lobectomy, to remove the chest tube within 24 h in 58.8%, and within 48 h in 82.5% of patients. As was also shown in other studies, this leads to shorter length of hospital stays, lower costs, and most importantly, reduces patient morbidity without the added risk of complications. #
Introduction
Drainage of the thorax after lung parenchyma resection by one or two chest tubes to mobilize air and fluid production is a standard procedure. However, chest tubes induce morbidity such as pain, and increase the risk of infection and immobilization [1] [2] [3] . Not only is this uncomfortable for the patient, but it also prolongs the length of hospital stays (LOSs) and increases costs. Therefore, chest tubes must be removed as soon as it is safe, and if no contribution to recovery is expected.
Air leakage has decreased with the introduction of staplers to divide the fissures. In complete video-assisted thoracoscopic surgery (c-VATS), the parenchymal resection depends on the use of staples. This has also reduced drainage duration in VATS chest-tube management [4] [5] [6] .
Early chest-tube protocols only removed a chest tube in case the fluid production was less then 150 ml (24 h)
À1
. Recently, more than one study reported the safe removal of the chest tube exceeding these volumes. Younes et al. reported safe removal at 200 ml (24 h) À1 after thoracotomy [3] ; McKenna et al. [6] showed it was safe at 300 ml (24 h) À1 after c-VATS and Cerfolio and Bryant reported successful removal of chest tubes up to 450 ml (24 h) À1 after thoracotomy [7] . To our knowledge, only one study, by Nakanishi et al., focusses on the removal of the chest tube after c-VATS lobectomy on postoperative day (POD) 1, without regard to drainage volume [8] . They showed that the removal of the chest tube on POD 1 is safe. They did leave a 7F back-up drain in place, which was removed on POD 4.
Simultaneously, with the introduction of c-VATS lobectomy [9] , we implemented a new protocol of chest-tube management. This was based on the removal of the chest tube within 24 h after resection, in case no active air leakage exists and fluid production is within 400 ml (24 h) À1 . The goal of this study is to evaluate this protocol and the safety of early removal of chest tubes after c-VATS (bi-)lobectomies. 
Materials and methods

Chest-tube protocol
The complete thoracoscopic lobectomy is performed as described by McKenna [10, 11] . The bronchus staple line is examined for leakage and, afterwards, all staple lines and dissection sites are sprayed with a fibrin sealant (Tissucol, 95 Baxter AB, Vienna, Austria). A chest tube, Ch 28, is inserted through the port of the videoscope and placed in the apex of the chest cavity. Lung expansion is checked under thoracoscopic vision, with positive airway pressure, until the chest tube is set on water seal. A chest X-ray is taken immediately postoperatively in the recovery room to see if the lung is fully expanded. Admittance to the intensive care unit (ICU) for overnight observation is indicated because there is no postoperative medium-care facility in our hospital, and the wards are insufficiently prepared for this kind of postoperative care. The chest tube is removed within 24 h, in case the fluid production is less then 400 ml (24 h) À1 and no active air leak is present. After removal of the chest tube, a control chest X-ray is only taken on clinical indication.
Patient inclusion
A retrospective cohort study was performed on a database consisting of data prospectively collected of all patients undergoing a c-VATS (bi-)lobectomy between March 2006 and December 2009. In case a c-VATS procedure was converted to an open thoracotomy, the patient was excluded from the study.
Our standard diagnostic staging protocol consists of a fullbody computed tomography/positron emission tomography (CT/PET) scan. In case of a suspected lymph node, either by increased diameter >1 cm on CT scan or an increased standard uptake value (SUV) on PET scan, we perform a diagnostic mediastinoscopy. The pulmonologist will perform a bronchoscopy with biopsy or lavage, or a CT-guided transthoracic biopsy.
During the outpatient consultation, all patients were informed about the procedure, the possible complications and the postoperative care. All patients signed their informed consent.
In all patients undergoing a lobectomy for non-small-cell lung cancer (NSCLC), a mediastinal lymph node sampling according to the Dutch guidelines for treatment of NSCLC was performed. This included for the right-upper and middle-lobe ipsilateral stations 2 and 4 and 7; right-lower lobe ipsilateral stations 4, and 7, 8 and 9; left-upper lobe stations 5, 6 and 7; and left-lower lobe ipsilateral stations 7, and 8 and 9.
Because the chest tube is removed based on a new hospital protocol, it was not necessary for the regional ethical committee to approve the study.
Patients are seen in the outpatient clinic 1 week and 1 month after discharge from the hospital. The oncological follow-up is done by the pulmonologist, according to Dutch standards. Chest X-rays at a later stage are taken, only if necessary, based on clinical examination.
Outcome
Analysis of the results was performed using Predictive Analytics SoftWare (PASW) Statistics 18 with the exact test and advanced statistics add-on modules. The min, q1, median, q3, and max were calculated for the duration of chest-tube placement, LOS, and duration at the ICU. The percentage of patients, who had the chest tube removed within 24 h and 48 h, was calculated. Other outcomes studied were the percentage of persisting air leak >6 days, subcutaneous emphysema, clinically relevant pneumothorax, placement of a new chest tube, re-operations, and major complications.
Results
Between March 2006 and December 2009, 134 patients were operated upon at the Atrium Medical Centre in Heerlen, the Netherlands, with the intention to perform a c-VATS (bi-)lobectomy. A total of 18 cases were converted to thoracotomy for reasons of limited vision, centrally located tumors, or uncontainable bleeding. Therefore, 116 patients with a complete c-VATS (bi-)lobectomy were included in the study. As many as 110 patients underwent (94.8%) a lobectomy, and six (5.2%) a bilobectomy. The median age at operation was 64.9 years, ranging from 18.3 to 85.7 years, q1 of 57.3 years and q3 of 72.2 years. Further patient characteristics are shown in Table 1 .
Indications were benign disease in seven patients (6.0%) and malignancy in 105 patients (90.5%). Details of pathology results are noted in Tables 2 and 3 . Preoperatively, one patient was staged IIIB or T4N0M0. Separate tumor nodules in one lobe classified the T4 descriptor, and a diagnostic mediastinoscopy was performed.
Three patients were preoperatively diagnosed with an M1 status, and thus stage IV. All had a solitary metastasis to the brain (T1/2N0M0), which was resected by the neurosurgeon, and followed by radiotherapy before the lobectomy. These patients also underwent a mediastinoscopy. The median duration of chest-tube placement was 1.0 day, ranging from 1 to 11 days, q1 of 1 day, and q3 of 2 days. A total of 58.8% (confidence interval (CI) 95%: 49.5-68.0) of the patients had the chest tube removed within 24 h of operation, and 82.5% (CI 95%: 74.2-88.7) within 48 h of operation. Only four patients had the chest tube in place for more than 6 days. Of these four patients, two had the chest tube removed on the 10th day and two on the 11th day, all cases caused by persisting air leakage.
The duration of the postoperative stay on the ICU was a median of 1.0 night, ranging from 0 to 5 days, q1 of 1 day, and q3 of 1 day. A total of 97% of cases was released from the ICU within 24 h after the operation. Only one patient was admitted to the ICU for 5 days' observation, because of known congestive heart problems and hemodialysis. The patient's stay in the hospital was uncomplicated apart from a minor bleeding out of an incision.
The median LOS was 4.0 days, ranging from 1 to 42 days, q1 of 3 days, and q3 of 7 days. A total of 67.8% was discharged from the hospital before POD 6.
In 98 patients (84.5%), no major postoperative complications occurred. Subcutaneous emphysema developed in six patients (6.2%) while the drain was still in place. We removed the chest tube and the subcutaneous emphysema resolved in a couple of days. It was not necessary to re-insert the chest tube.
Persisting air leakage was seen in four (3.4%) patients. In one case, it was necessary to insert a new chest tube; another patient had a small tear of the lung, which was controlled thoracoscopically by sealing with Co-seal (95 Baxter AB, Vienna, Austria).
A pneumothorax was seen in one (0.9%) patient, after removal of the chest tube on POD 3. This patient received a small one-way thoracic catheter (Pleuracath W , Plastimed, St. Leu-la-Fôret, France) resulting in a quick recovery. No other interventions were performed.
Postoperative in-hospital mortality was 0.9% (one patient). The patient who died had pneumonia at the nonoperated side. All complications are described in Table 4 .
At 1-week follow-up, no clinically relevant pneumothorax was seen. Neither was a pneumothorax diagnosed at 1-month follow-up.
Discussion
The introduction of minimal invasive surgery (MIS) in thoracic surgery is probably one of the main reasons for the increased interest in chest-tube management. MIS lowered postoperative pain [12] and, therefore, the pain caused by drainage of the chest became more prominent.
Awareness was raised among surgeons, resulting in early removal of this pain-inducing device. Several recently published studies discuss chest-tube management with early removal of the chest tube after lung resection [4] [5] [6] [7] .
From a theoretical point of view, chest tubes seem less crucial after VATS. Air leakage is reduced by the abundant use of staples. Together with spraying the dissected tissues, staple lines and unintentional lacerations with a fibrin sealant as Tissuecol, as we routinely do, even before the introduction of the c-VATS technique, probably results in practically no air leakage at all. Data support this observation [13] .
Apart from the above-mentioned arguments, c-VATS lowers the surgical trauma because no rib-spreading instruments are used and smaller incisions are made, probably resulting in less drainage production and, therefore, less fluid evacuation is needed.
In our new protocol, which was implemented together with the introduction of c-VATS lobectomy in March 2006 [9] , we strive for removal of the chest tube on the first POD. In contrast to Nakanishi et al. [8] , we do not use a back-up chest tube. We limit the drainage volume to 400 ml (24 h) À1 as was also done in several other studies [4, 14] .
The results of our study show that a high percentage of patients had the chest tube removed within 24 h of operation and there was an even higher percentage of chest-tube removal within 48 h. Drainage volume over 400 ml (24 h) À1 , in 11 patients (9.5%), was, in most cases, the reason for the chest-tube removal after more than 24 h. The chest tube itself can probably be the cause of prolonged fluid loss, and the best treatment is to remove the device that causes the problem. Postoperative hemorrhage is very rarely seen after the first 24 h and, if so, should always be treated aggressively, but this did not occur in our series. The median LOS of 4.0 days seems long if we remove the chest tube within 24 h. However, it is common in our hospital to admit the patients on the day before the operation, which adds one extra day to the LOS. Besides, we have been operating older and physically less-fit patients, because our experience with the c-VATS lobectomy is improving. Frequently, older patients are not discharged home and need to be admitted to social homes, which can take weeks before a location becomes available.
None of the postoperatively taken chest X-rays led to an intervention. McKenna et al. [6] discuss that there is no need for these postoperative chest X-rays. Our results corroborate this policy.
A complication only occasionally experienced in openlung surgery, but relatively frequently seen in c-VATS, is subcutaneous emphysema. The underlying mechanism might be air suction alongside the chest tube, which is placed through the relatively wide videoscopic port. Therefore, we keep this opening as small as possible and tunnel the incision in the subcutaneous tissue. We close the subcutaneous tissue as well as the skin around the chest tube meticulously. The incision site is sprayed with fluid plaster and covered with gauzes. In the case of subcutaneous emphysema, we were very successful by just removing the drain, supporting the theory of the cause of this complication.
If air leakage is prolonged and caused by a parenchymal tear, we agree with Cerfolio et al. [15] that a pneumolysis with c-VATS should be performed, if a period of suction to the chest tube does not solve the problem. We then prefer to use sealants such as Co-seal and Tissuecol. Outpatient devices such as Heimlich valves were not used.
Recently published studies comparing one and two chest tubes reported less pain, less costs and no adverse consequences in the single-drain group [1, 2, 16] . Favorable results obtained by us by using only one chest tube confirm these findings.
Regarding suction, several studies show water seal is just as effective in preventing air leakage, postoperatively [17, 18] . These findings are also in line with our results.
This study shows it is safe, after c-VATS (bi-)lobectomy, to remove the chest tube within 24 h in 58.8%, and within 48 h in 82.5% of cases. As was also shown in other studies, this leads to shorter LOS, less costs, and, most importantly, reduces patient morbidity.
